Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANNFIB: Medical Cannabis (Cannabidiol) for Fibromyalgia
2019-002394-59Phase 2Completed
- Sponsor
- Parker Institute for Cancer Immunotherapy
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cannabidiol in fibromyalgia (FM), sponsored by Parker Institute for Cancer Immunotherapy. Primary endpoint: Change in pain intensity. Started Jul 2020; status: completed.
02
Drugs
cannabidiol
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2019-002394-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002394-59.